← Open Payments lookup

CHARMAINE HEBERT: Open Payments

NPI 1225341019 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$741 in 43 payments from 11 companies in 2025. Trend: 2023 $794 · 2024 $767 · 2025 $741

Food & beverage: $741
CompanyPaymentsAmount
Lilly USA, LLC14$217
ABBVIE INC.5$165
Novo Nordisk Inc5$96
Amgen Inc.4$62
AstraZeneca Pharmaceuticals LP3$53
Takeda Pharmaceuticals U.S.A., Inc.2$44
Exact Sciences Corporation2$34
Kowa Pharmaceuticals America, Inc.1$22
Noven Therapeutics, LLC1$19
Phathom Pharmaceuticals, Inc.5$16

Products named: VRAYLAR, JARDIANCE, MOUNJARO, AIRSUPRA, Ozempic, OTEZLA, KISUNLA, TRINTELLIX.

Industry payments across LA — which companies pay providers there.